PeproTech重组人TL-1A 20ug-细胞/细菌培养-试剂-生物在线
美国PeproTech(派普泰克)公司中国代表处
PeproTech重组人TL-1A 20ug

PeproTech重组人TL-1A 20ug

商家询价

产品名称: PeproTech重组人TL-1A 20ug

英文名称: Recombinant Human TL-1A

产品编号: 310-23

产品价格: 0

产品产地: 美国

品牌商标: PeproTech

更新时间: null

使用范围: null

美国PeproTech(派普泰克)公司中国代表处
  • 联系人 :
  • 地址 :  江苏省苏州市工业园区星湖街218号A1北座4楼L03
  • 邮编 : 215123
  • 所在区域 : 江苏
  • 电话 : 点击查看
  • 传真 : 点击查看
  • 邮箱 : peprotech.infochina@thermofisher.com

 

Human Growth Factors & Cytokines

Recombinant Human TL-1A



 

Synonyms :

TNFSF15, VEGI

Description :

TL-1A belongs to the TNF superfamily of ligands. It is expressed predominantly in endothelial cells, and to a lesser extent in placenta, lung, kidney, skeletal muscle, pancreas, small intestine and colon. TL-1A inhibits endothelial cell proliferation and angiogenesis, and has been shown to induce NFkB activation, caspase activity, and apoptosis in responding cell lines. TL-1A interacts with TNFRSF25/DR3 receptor, but can also bind to a decoy receptor TNFRSF21/DR6. Recombinant human TL-1A is a 22.0 kDa polypeptide of 194 amino acid residues.

Catalog #:

310-23

Source :

E.coli

Purity :

Greater than 98% by SDS-PAGE gel and HPLC analyses.

Endotoxin Level :

Endotoxin level is less than 0.1 ng per μg (1EU/μg).

Biological Activity :

Determined by its ability to stimulate IFN-γ production by human PBMC using a concentration range of 10.0-100.0 ng/ml. Note: Results may vary with PBMC donors.

Selected References :

Selected List of References Citing This PeproTech Product

AA Sequence :

QLRAQGEASV QFQALKGQEF APSHQQVYAP LRADGDKPRA HLTVVRQTPT QHFKNQFPAL HWEHELGLAF TKNRMNYTNK FLLIPESGDY FIYSQVTFRG MTSECSEIRQ AGRPNKPDSI TVVITKVTDS YPEPTQLLMG TKSVCEVGSN WFQPIYLGAM FSLQEGDKLM VNVSDISLVD YTKEDKTFFG AFLL

PubMed Link :

TNFSF15

Country of Origin :

USA


Size A 5μg $80   
 
Size B 20μg $195   
 
Size C 1mg $3000   
 


Special Sizes:
Many products can be ordered in custom sizes. Please click here to contact Peprotech with your request.

Usage:
For Research Use Only. Not for use in diagnostic or therapeutic procedures.